No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
52 |
4. Check minimum number of eventsNone |
52 |
5. Include endpointsNone |
52 |
6. Filter based on genotype QC (FinnGen only) |
52 |
Control definitions (FinnGen only)
- Control exclude
- M13_SYSTCONNECT
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M35
- Name in latin
- Fasci[i]tis [eosinophila] diffusa
Similar endpoints
↥List of similar endpoints to
Diffuse (eosinophilic) fasciitis
based on the number of shared cases.
Similar with more cases:
- Other systemic involvement of connective tissue
- Systemic connective tissue disorders
- Diseases of the musculoskeletal system and connective tissue
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 308 | 198 | 108 |
| Only index persons | 287 | 185 | 102 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.00 | 0.01 | 0.00 |
| Only index persons | 0.01 | 0.01 | 0.00 |
| Median age at first event (years) | |||
| Whole population | 58.90 | 60.24 | 56.13 |
| Only index persons | 56.83 | 58.34 | 54.10 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 52 | 36 | 16 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 58.31 | 56.87 | 61.53 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3037522) Nuclear Ab [Titer] in Serum
27
47
10.87
16.98
1.6
1.3
titre
152.0
342.2
—
5
9
(3015171) Extractable nuclear Ab [Units/volume] in Serum
13
8
21.05
9.11
1.2
1.0
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
14
23
7.96
8.69
2.2
2.3
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
35
138
5.70
8.56
5.0
1.8
u/l
83.7
146.1
1.51
35
133
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
10
11
11.02
8.36
2.0
5.1
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
40
185
6.04
7.85
20.6
5.9
%
2.7
2.5
0.46
40
172
(3007164) IgA [Mass/volume] in Serum or Plasma
26
86
5.05
7.71
2.3
1.4
g/l
2.3
2.2
0.17
18
49
(3022096) Basophils/100 leukocytes in Blood
39
179
5.72
7.66
20.8
5.7
%
0.7
0.6
0.91
39
164
(3019069) Monocytes/100 leukocytes in Blood
40
188
5.89
7.61
21.0
6.4
%
9.1
8.5
0.77
40
176
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
10
13
9.29
7.38
2.8
1.8
mg/l
16.2
9.7
—
10
13
(3002030) Lymphocytes/100 leukocytes in Blood
40
193
5.65
7.23
20.9
6.2
%
28.2
27.7
0.10
40
178
(3018010) Neutrophils/100 leukocytes in Blood
39
191
5.17
6.74
20.1
6.1
%
55.0
57.3
0.75
39
179
(42870588) Differential panel, method unspecified - Blood
31
128
4.52
6.72
18.7
5.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
12
23
6.48
6.35
1.9
4.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
32
143
4.22
6.06
4.3
5.0
ph
7.4
7.4
—
8
28
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
9
8
13.26
5.53
1.2
1.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
38
202
4.27
5.42
6.5
6.8
mmol/l
1.2
1.2
0.55
38
186
(3021440) Promyelocytes/100 leukocytes in Blood
13
32
5.08
5.26
7.3
4.3
%
0.0
0.3
—
6
8
(3025159) Blasts/100 leukocytes in Blood
13
32
5.08
5.26
7.2
4.3
%
0.0
1.3
—
6
6
(3017181) Myelocytes/100 leukocytes in Blood
14
38
4.67
5.04
6.9
4.1
%
0.8
1.0
—
6
11
(3035350) Ketones [Presence] in Urine by Test strip
39
218
4.16
5.02
5.1
3.5
estimate
0.0
0.0
—
8
41
(3021601) Nitrite [Presence] in Urine by Test strip
39
218
4.16
5.02
7.2
4.6
estimate
0.0
0.0
—
9
44
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
8
9
10.23
4.45
2.3
6.0
g/l
0.0
0.0
—
8
9
(3017143) Hepatitis C virus Ab [Presence] in Serum
16
53
3.92
4.42
1.2
1.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
12
32
4.58
4.37
7.8
4.2
%
0.7
0.0
—
6
6
(46235355) HIV 1 and 2 tests - Meaningful Use set
17
61
3.65
4.18
1.4
1.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
38
226
3.53
4.09
5.3
3.5
estimate
0.0
0.0
—
7
41
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
8
11
8.35
4.02
1.9
1.9
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
47
341
4.92
3.87
13.7
3.8
mm/h
11.0
11.8
0.21
47
309
(3021879) Hepatitis B virus core Ab [Presence] in Serum
11
31
4.23
3.71
1.2
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
6
11.07
3.59
1.0
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
22
101
3.04
3.59
4.5
3.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
9
18
5.80
3.55
1.0
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
16
62
3.28
3.44
1.3
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
20
93
2.87
3.13
9.9
6.6
—
—
—
0
0
(3015736) pH of Urine
29
167
2.67
2.97
4.1
3.3
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
47
365
3.98
2.95
17.4
7.9
u/l
67.4
78.5
1.64
47
334
(40760888) Immunoglobulin light chains.free panel - Serum
5
6
9.04
2.81
2.0
12.7
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
6
9.04
2.81
1.6
1.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
12
46
3.09
2.57
2.8
3.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
8
6.77
2.42
1.8
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
5
8
6.77
2.42
1.2
1.4
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
5
8
6.77
2.42
1.2
1.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
26
153
2.40
2.42
5.8
3.3
e6/l
14.7
74.6
1.56
16
112
(3037467) Urinalysis macro (dipstick) panel - Urine
42
309
2.87
2.38
10.8
4.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
6
13
5.06
2.34
1.3
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
9
6.00
2.26
3.6
2.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
16
77
2.56
2.26
1.1
1.2
iu/ml
10.2
21.3
—
5
22
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
7
19
4.09
2.24
1.4
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
10
5.40
2.12
1.0
1.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
8
26
3.44
2.11
1.1
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
6
15
4.37
2.10
1.7
1.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
21
120
2.26
2.02
21.1
9.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
20
125
1.98
1.46
5.8
3.7
estimate
0.0
0.0
—
9
40
(4035726)
9
41
2.44
1.46
1.4
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
9
42
2.38
1.42
9.8
5.5
%
2.1
1.9
—
9
37
(3007853) Bacteria identified in Skin by Aerobe culture
8
38
2.30
1.25
1.1
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
25
179
1.76
1.15
2.2
2.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
5
21
2.52
1.11
1.6
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
41
344
1.91
1.05
3.7
4.1
pmol/l
14.7
14.8
0.20
35
311
(3024561) Albumin [Mass/volume] in Serum or Plasma
26
193
1.69
1.03
3.5
5.1
g/l
34.8
35.9
0.53
26
185
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
24
176
1.68
0.98
5.9
3.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
6
27
2.38
0.97
1.2
1.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
22
159
1.66
0.94
4.0
2.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
6
29
2.20
0.93
1.5
2.0
—
—
—
0
0
(3000492) Spirometry study
6
30
2.13
0.90
1.5
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6
30
2.13
0.90
1.5
2.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
18
125
1.67
0.88
5.4
3.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
9
52
1.88
0.82
2.0
1.8
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
5
23
2.29
0.78
7.4
8.0
mmol/l
27.6
24.9
—
5
23
(3002385) Erythrocyte distribution width [Ratio]
42
369
1.72
0.74
36.7
17.4
%
14.2
13.8
1.06
42
363
(3044640) Blood type and Crossmatch panel - Blood
20
149
1.56
0.73
4.4
2.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
5
26
2.02
0.73
2.2
1.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
11
70
1.72
0.72
2.2
1.8
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
10
63
1.73
0.67
1.2
1.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
31
259
1.49
0.64
6.6
6.7
umol/l
10.6
10.7
0.02
31
240
(3042936) Bacteria identified in Isolate by Culture
10
64
1.70
0.64
1.7
2.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
8
52
1.63
0.63
2.1
1.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
23
182
1.47
0.62
4.8
3.6
ng/l
16.0
32.4
0.84
18
130
(1002224) Polysomnography panel
0
19
0.00
0.61
0.0
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
21
0.00
0.61
0.0
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
9
61
1.57
0.58
1.1
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
6
37
1.70
0.58
2.2
4.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
11
152
0.65
0.55
2.3
3.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
15
111
1.49
0.54
6.7
3.9
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
16
121
1.47
0.52
3.6
2.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
10
70
1.53
0.46
2.0
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
5
31
1.68
0.44
1.4
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
21
173
1.36
0.42
2.2
1.9
pmol/l
92.4
100.4
—
10
78
(3044889) 12 lead EKG panel
35
312
1.37
0.42
3.9
3.9
—
—
—
0
0
(3022621) pH of Urine by Test strip
5
36
1.43
0.39
2.2
3.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
6
41
1.52
0.37
9.7
3.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
10
76
1.39
0.31
2.1
2.4
e6/l
0.4
0.9
—
5
44
(3009542) Hematocrit [Volume Fraction] of Blood
38
404
0.78
0.25
32.2
15.1
%
37.8
40.2
0.56
28
279
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
24
215
1.22
0.22
4.4
4.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
28
255
1.21
0.22
2.3
2.7
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
3.0
—
0
6
(3003740) Influenza virus B Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
6
49
1.25
0.21
1.0
1.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
12
142
0.80
0.21
5.8
2.4
u/l
69.8
56.2
0.56
12
133
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
3.6
—
63.6
—
0
14
(3022948) Iron [Moles/volume] in Serum or Plasma
8
68
1.21
0.18
2.9
2.4
umol/l
19.4
13.8
—
8
58
(3020682) Albumin/Creatinine [Ratio] in Urine
12
137
0.84
0.14
6.0
3.9
mg/mmol
5.3
11.6
—
7
85
(3019225) pH of Specimen
5
44
1.15
0.10
9.0
4.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
10
113
0.86
0.09
3.0
2.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
6
53
1.15
0.09
1.7
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
46
466
0.89
0.09
21.6
12.9
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
5
62
0.79
0.09
4.0
2.4
g/l
2.5
2.5
—
5
53
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
6
71
0.83
0.08
1.3
1.4
—
—
—
0
0
(3013512) EKG study
13
139
0.91
0.04
6.5
3.9
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
12
127
0.93
0.02
4.3
3.0
mg/l
23.7
65.8
—
7
80
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
29
297
0.95
0.01
3.2
2.9
u/l
34.7
48.0
1.35
29
272
(1761868) Lipid panel - Serum or Plasma
14
141
0.99
0.00
2.4
3.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
13
127
1.03
0.00
1.8
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(4281824)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
0
6
0.00
0.00
0.0
1.2
—
189.5
—
0
6
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
0
6
0.00
0.00
0.0
1.0
—
388.0
—
0
6
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
7
0.00
0.00
0.0
3.4
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(4146454)
0
7
0.00
0.00
0.0
3.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
2.0
—
1.4
—
0
5
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
2.0
—
32.2
—
0
5
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
99.4
—
0
5
(3016879) Cocaine [Presence] in Urine
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
0
5
0.00
0.00
0.0
1.6
—
91.6
—
0
5
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(44813793)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_DIFFASCITIS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_DIFFASCITIS | 1.827 [1.31, 2.54] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.086 |
During the follow-up period (1.1.1998 — 31.12.2019), 55 out of 174 females with M13_DIFFASCITIS died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have M13_DIFFASCITIS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.141% | No data |
| 5 | 0.953% | No data |
| 10 | 2.411% | No data |
| 15 | 4.638% | No data |
| 20 | 8.067% | No data |
Relationships between endpoints
↥Index endpoint: M13_DIFFASCITIS – Diffuse (eosinophilic) fasciitis
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data